Genetic contributors toward increased risk for ischemic heart disease

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 4, 2005, Pages 667-679

  Nordlie, Margaret A ^b   Wold, Loren E ^a   Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MARY   (United States)

Author keywords

Coronary artery disease; Genetics; Hemostasis; Lipid metabolism; Myocardial infarction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALCOHOL DEHYDROGENASE; ALDOSTERONE SYNTHASE; ALPHA2 INTEGRIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; APOLIPOPROTEIN B100; BLOOD CLOTTING FACTOR 5 LEIDEN; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOGEN RECEPTOR; INTERLEUKIN 6; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBOSPONDIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE COURSE; DNA POLYMORPHISM; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; GENE EXPRESSION; GENETIC DISORDER; GENETIC PREDISPOSITION; HEALTH CARE COST; HEART INFARCTION; HOMEOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 24944498879     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.06.006     Document Type: Article

References (92)

1. American Heart Association. Heart disease and stroke statistics - 2005 update. Dallas, TX: Am. Heart Assoc; www.americanheart.org/2005.
2. R.A. Chaer, R. Billeh, and M.G. Massad Genetics and gene manipulation therapy of premature coronary artery disease Cardiology 101 2004 122 130
3. P.J. Talmud How to identify gene-environment interactions in a multifactorial disease: CHD as an example Proc. Nutr. Soc. 63 2004 5 10
4. L.B. Jorde, J.C. Carey, M.J. Bamshad, and R.L. White Medical genetics. 3rd ed 2003 Mosby St. Louis
5. M.E. Marenberg, N. Risch, L.F. Berkman, B. Floderus, and U. de Faire Genetic susceptibility to death from coronary heart disease in a study of twins N. Engl. J. Med. 330 1994 1041 1046
6. J.P.A. Ioannidis, E.E. Ntzani, T.A. Trikalinos, and D.G. Contopoulos-Ioannidis Replication validity of genetic association studies Nat. Genet. 29 2001 306 309
7. B.R. Winkelmann, J. Hager, W.E. Kraus, P. Merlini, B. Keavney, and P.J. Grant Genetics of coronary heart disease: current knowledge and research principles Am. Heart J. 140 2000 S11 S26
8. A.G. Motulsky, and J.D. Brunzell Genetics of coronary atherosclerosis R.A. King J.I. Rotter A.G. Motulsky The genetic basis of common diseases 2nd ed. 2002 Oxford University Press Oxford, UK
9. National Center for Biotechnology Information. OMIM: Online Mendelian inheritance in man. 143890 Hypercholesterolemia, autosomal dominant (FH). www.ncbi.nlm.nih.gov/omim/, 2005.
10. National Center for Biotechnology Information. OMIM: Online Mendelian inheritance in man. 144010 Hypercholesterolemia, autosomal dominant, type B (familial defective apolipoprotein B-100). www.ncbi.nlm.nih.gov/omim/, 2005.
11. M. Abifadel, M. Varret, J.-P. Rabes, D. Allard, K. Ouguerram, and M. Devillers Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat. Genet. 34 2003 154 156
12. K.M. Timms, S. Wagner, M.E. Samuels, K. Forbey, H. Goldfine, and S. Jammulapati A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree Hum. Genet. 114 2004 349 353
13. T.P. Leren Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia Clin. Genet. 65 2004 419 422
14. National Center for Biotechnology Information. OMIM: Online Mendelian inheritance in man. 603776 Hypercholesterolemia, autosomal dominant, 3 (HCHOLA3). www.ncbi.nlm.nih.gov/omim/, 2005.
15. J. Cohen, A. Pertsemlidis, I.K. Kotowski, R. Graham, C.K. Garcia, and H.H. Hobbs Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 Nat. Genet. 37 2005 161 165
16. M.A. Austin, C.M. Hutter, R.L. Zimmern, and S.E. Humphries Familial hypercholesterolemia and coronary heart disease: a HuGE association review Am. J. Epidemiol. 160 2004 421 429
17. S.N. Chen, C.M. Ballantyne, A.M. Gotto Jr., Y. Tan, J.T. Willerson, and A.J. Marian A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis J. Am. Coll. Cardiol. 45 2005 1611 1619
18. R.L. Nussbaum, R.R. McInnes, and H.F. Willard Genetics in medicine. 6th ed 2004 Saunders Philadelphia
19. T.L. Innerarity, R.W. Mahley, K.H. Weisgraber, T.P. Bersot, R.M. Krauss, and G.L. Vega Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia J. Lipid Res. 31 1990 1337 1349
20. L.F. Soria, E.H. Ludwig, H.R.G. Clarke, G.L. Vega, S.M. Grundy, and B.J. McCarthy Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 Proc. Natl. Acad. Sci. USA 86 1989 587 591
21. A. Tybjaerg-Hansen, and S. Humphries Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease Atherosclerosis 96 1992 91 107
22. A.R. Miserez, R. Laager, N. Chiodette, and U. Keller High prevalence of familial defective apolipoprotein B-100 in Switzerland J. Lipid Res. 35 1994 574 583
23. P.S. Hansen, J.C. Defesche, J.J.P. Kastelein, L.U. Gerdes, L. Fraza, and C. Gerdes Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries Arterioscler. Thromb. Vasc. Biol. 17 1997 741 747
24. J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J. Clin. Invest. 52 1973 1544 1568
25. National Center for Biotechnology Information. OMIM: Online Mendelian inheritance in man. 144250 Hyperlipidemia, familial combined (FCHL). www.ncbi.nlm.nih.gov/omim/, 2005.
26. C.C. Shoulders, E.L. Jones, and R.P. Naoumova Genetics of familial combined hyperlipidemia and risk of coronary heart disease Hum. Mol. Genet. 13 2004 R149 R160
27. J.D. Brunzell, H.G. Schrott, A.G. Motulsky, and E.L. Bierman Myocardial infarction in the familial forms of hypertriglyceridemia Metabolism 25 1976 313 320
28. J.J. Genest Jr., S.S. Martin-Munley, J.R. McNamara, J.M. Ordovas, J. Jenner, and R.H. Myers Familial lipoprotein disorders in patients with premature coronary artery disease Circulation 85 1992 2025 2033
29. P.N. Hopkins, G. Heiss, R.C. Ellison, M.A. Province, J.S. Pankow, and J.H. Eckfeldt Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia Circulation 108 2003 519 523
30. M. O'Toole Miller-Keane encyclopedia and dictionary of medicine, nursing, and allied health 2003 Elsevier Science USA
31. National Center for Biotechnology Information. OMIM: Online Mendelian inheritance in man. 145750 Hypertriglyceridemia, familial (FHTG). www.ncbi.nlm.nih.gov/omim/, 2005.
32. J.-T. Kao, H.-C. Wen, K.-L. Chien, H.-C. Hsu, and S.-W. Lin A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia Hum. Mol. Genet. 12 2003 2533 2539
33. R. Duggirala, J. Blangero, L. Almasy, T.D. Dyer, K.L. Williams, and R.J. Leach A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans Am. J. Hum. Genet. 66 2000 1237 1245
34. National Center for Biotechnology Information. OMIM: Online Mendelian inheritance in man. 108725 Atherosclerosis susceptibility (ATHS). www.ncbi.nlm.nih.gov/omim/, 2005.
35. M.A. Austin, J.L. Breslow, C.H. Hennekens, J.E. Buring, W.C. Willett, and R.M. Kraus Low-density lipoprotein subclass patterns and risk of myocardial infarction J. Am. Med. Assoc. 260 1988 1917 1921
36. J.I. Rotter, X. Bu, R.M. Cantor, C.H. Warden, J. Brown, and R.J. Gray Multilocus genetic determinants of LDL particle size in coronary artery disease families Am. J. Hum. Genet. 58 1996 585 594
37. P.M. Nishina, J.P. Johnson, J.K. Naggert, and R.M. Krauss Linkage for atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19 Proc. Natl. Acad. Sci. USA 89 1992 708 712
38. J.K. Naggert, A. Recinos III, J.E. Lamerdin, R.M. Krauss, and P.M. Nishina The atherogenic lipoprotein phenotype is not caused by a mutation in the coding region of the low density lipoprotein receptor gene Clin. Genet. 51 1997 236 240
39. L. Wang, C. Fan, S.E. Topol, E.J. Topol, and Q. Wang Mutation of MEF2A in an inherited disorder with features of coronary artery disease Science 302 2003 1578 1581
40. P.W. Wilson, E.J. Schaefer, M.G. Larson, and J.M. Ordovas Apolipoprotein E alleles and risk of coronary disease: a meta-analysis Arterioscler. Thromb. Vasc. Biol. 16 1996 1250 1255
41. L.U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I.C. Klausen, and P.S. Hansen The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study Circulation 101 2000 1366 1371
42. Y. Song, M.J. Stampfer, and S. Liu Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease Ann. Intern. Med. 141 2004 137 147
43. H.W. Marshall, L.C. Morrison, L.L. Wu, J.L. Anderson, P.S. Corneli, and D.M. Stauffer Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study Circulation 89 1994 567 577
44. S.E. Humphries, P.J. Talmud, E. Hawe, M. Bolla, I. Day, and G.J. Miller Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study Lancet 358 2001 115 119
45. P.J. Talmud, S.J. Lewis, E. Hawe, S. Martin, J. Acharya, and M.G. Marmot No APOE ε4 effect on coronary heart disease risk in a cohort with low smoking prevalence: the Whitehall II study Atherosclerosis 177 2004 105 112
46. H.H. Wittrup, A. Tybjærg-Hansen, and B. Nordestgaard Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease: a meta-analysis Circulation 99 1999 2901 2907
47. P.J. Talmud, S. Bujac, S. Hall, G.J. Miller, and S.E. Humphries Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of coronary heart disease in male smokers Atherosclerosis 149 2000 75 81
48. R.A. Hegele, L.S. Huang, P.N. Herbert, C.B. Blum, J.E. Buring, and C.H. Hennekens Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction N. Engl. J. Med. 315 1986 1509 1515
49. A. Tybjærg-Hansen, R. Steffensen, H. Meinertz, P. Schnohr, and B.G. Nordestgaard Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease N. Engl. J. Med. 338 1998 1577 1584
50. M. Tatsuguchi, M. Furutani, J. Hinagata, T. Tanaka, Y. Furutani, and S. Imamura Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction Biochem. Biophys. Res. Commun. 303 2003 247 250
51. R. Mango, F. Clementi, P. Borgiani, G.B. Forleo, M. Federici, and G. Contino Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction J. Med. Genet. 40 2003 933 936
52. Q. Chen, S.E. Reis, C. Kammerer, W.Y. Craig, S.E. LaPierre, and E.L. Zimmer Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease Circulation 107 2003 3146 3151
53. J.P. Cooke, and V.J. Dzau Nitric oxide synthase: role in the genesis of vascular disease Annu. Rev. Med. 48 1997 489 509
54. X.L. Wang, A.S. Sim, R.F. Badenhop, R.M. McCredie, and D.E. Wilcken A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene Nat. Med. 2 1996 41 45
55. S. Ichihara, Y. Yamada, T. Fujimura, N. Nakashima, and M. Yokota Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population Am. J. Cardiol. 81 1998 83 86
56. W.C. Hooper, C. Lally, H. Austin, J. Benson, A. Dilley, and N.K. Wenger The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans Chest 116 1999 880 886
57. J.P. Casas, L.E. Bautista, S.E. Humphries, and A.D. Hingorani Endothelial nitric oxide synthase genotype and ischemic heart disease: Meta-analysis of 26 studies involving 23028 subjects Circulation 109 2004 1359 1365
58. B. Keavney, C. McKenzie, S. Parish, A. Palmer, S. Clark, and L. Youngman Large-scale test of hypothesized associations between the angiotensin- converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls Lancet 355 2000 434 442
59. B. Rigat, C. Hubert, F. Alhene-Gelas, F. Cambien, P. Corvol, and F. Soubrier An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J. Clin. Invest. 86 1990 1343 1346
60. E.H. Ludwig, I.B. Borecki, R.C. Ellison, A.R. Folsom, G. Heiss, and M. Higgins Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: The NHLBI family heart study Ann. Epidemiol. 7 1997 3 12
61. L. Tiret, A. Bonnardeaux, O. Poirier, S. Ricard, P. Marques-Vidal, and A. Evans Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction Lancet 344 1994 910 913
62. G.K. Andrikopoulos, S.M. Tzeis, E.W. Needham, D.J. Richter, M.N. Zairis, and E. Gialafos Lack of association between common polymorphisms in genes of the renin-angiotensin system and mortality after myocardial infarction Cardiology 103 2005 185 188
63. S. Patel, R. Steeds, K. Channer, and N.J. Samani Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction Am. J. Hypertens. 13 2000 134 139
64. A. Hautanen, P. Toivanen, M. Manttari, L. Tenkanen, V. Manninen, and M.M. Kayes Variations of aldosterone synthase gene and risk of coronary heart disease in dyslipidemic middle-aged men Circulation 98 1998 1531 1532
65. 807T gene polymorphism with nonfatal myocardial infarction in younger patients Blood 93 1999 2449 2453
66. A.P. Reiner, D.S. Siscovick, and F.R. Rosendaal Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women Br. J. Haematol. 112 2001 632 636
67. T. Hato, Y. Minamoto, T. Fukuyama, and S. Fujita Polymorphisms of the HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population Am. J. Cardiol. 80 1997 1222 1224
68. A2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: The Copenhagen City Heart Study J. Am. Coll. Cardiol. 42 2003 661 667
69. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis Lancet 349 1997 385 388
70. E.J. Topol, J. McCarthy, S. Gabriel, D.J. Moliterno, W.J. Rogers, and K. Newby Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction Circulation 104 2001 2641 2644
71. J.S. Greengard, X. Sun, X. Xu, G.A. Fernandez, J.H. Griffin, and B. Evatt Activated protein C resistance caused by Arg506Gln mutation in factor Va Lancet 343 1994 1361 1362
72. T. Koster, F.R. Rosendaal, H. deRonde, E. Briet, J.P. Vandenbroucke, and R.M. Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Lancet 342 1993 1503 1506
73. F.R. Rosendaal, T. Koster, J.P. Vandenbroucke, and P.H. Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
74. F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, R.K. Beverly, B.M. Psaty, and W.T. Longstreth Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women Blood 89 1997 2817 2821
75. F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, B.M. Psaty, T.E. Raghunathan, and H.L. Vos A common prothrombin variant (20210G to A) increases the risk of myocardial infarction in young women Blood 90 1997 1747 1750
76. G. Endler, and C. Mannhalter Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis Clin. Chim. Acta 330 2003 31 55
77. B. Voetsch, and J. Loscalzo Genetics of thrombophilia: impact on atherogenesis Curr. Opin. Lipidol. 15 2004 129 143
78. P. Eriksson, and B. Kallin van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc. Natl. Acad. Sci. USA 92 1995 1851 1855
79. J.L. Anderson, J.B. Muhlestein, J. Habashi, J.F. Carlquist, T.L. Bair, and S.P. Elmer Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction J. Am. Coll. Cardiol. 34 1999 1778 1783
80. D.E.L. Wilcken, and B. Wilcken The pathogenesis of coronary artery disease: a possible role for methionine metabolism J. Clin. Invest. 57 1976 1079 1082
81. M.J. Stampfer, M.R. Malinow, W.C. Willett, L.M. Newcomer, B. Upson, and D. Ullmann A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians J. Am. Med. Assoc. 268 1992 877 881
82. L. Brattström, D.E.L. Wilcken, J. Öhrvik, and L. Brudin Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis Circulation 98 1998 2520 2526
83. M. Klerk, P. Verhoef, R. Clarke, H. Blom, F. Kok, and E.G. Schouten MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis J. Am. Med. Assoc. 288 2002 2023 2031
84. S.E. Humphries, L.A. Luong, M.S. Ogg, E. Hawe, and G.J. Miller The interleukin-6-174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men Eur. Heart J. 22 2001 2243 2252
85. D. Kelberman, E. Hawe, L.A. Luong, V. Mohamed-Ali, P. Lundman, and P. Tornvall Effect of interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH study Thromb. Haemost. 92 2004 1122 1128
86. S. Francke, M. Manraj, C. Lacquemant, C. Lecoeur, F. Lepretre, and P. Passa A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27 Hum. Mol. Genet. 10 2001 2751 2765
87. P. Pajukanta, M. Cargill, L. Viitanen, I. Nuotio, A. Kareinen, and M. Perola Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland Am. J. Hum. Genet. 67 2000 1481 1493
88. U. Broeckel, C. Hengstenberg, B. Mayer, S. Holmer, L.J. Martin, and A.G. Comuzzie A comprehensive linkage analysis for myocardial infarction and its related risk factors Nat. Genet. 30 2002 210 214
89. E.R. Hauser, D.C. Crossman, C.B. Granger, J.L. Haines, C.J.H. Jones, and V. Mooser A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD study Am. J. Hum. Genet. 75 2004 436 447
90. W.F. Bosron, L. Lumeng, and T.K. Li Genetic polymorphisms of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease Mol. Aspects Med. 10 1988 147 158
91. L.M. Hines, M.J. Stampfer, J. Ma, J.M. Gaziano, P.M. Ridker, and S.E. Hankinson Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction N. Engl. J. Med. 344 2001 549 555
92. E.J. Topol Cholesterol, racial variation and targeted medicines Nat. Med. 11 2005 122 123